Live
- Second phase randomization of EVMs is complete
- BJP confusing Matua voters though CAA notification: Mamata Banerjee
- IPL 2024: LSG might have to play the rest of the event without Mayank Yadav, says coach Justin Langer
- Two killed after colliding with a parked lorry
- PCB identifies the April 7- May 20 window for PSL 2025; to clash with IPL’s next season
- Viksit Bharat Ambassador event: Sri Sri Ravi Shankar heaps praise on PM Modi for Kashi facelift
- Women’s Hockey League: Haryana, Madhya Pradesh win on Day 5
- Indian Americans caution US university on demand to display 'flag of Kashmir'
- YS Sharmila worried over 'mental state' of brother Jagan
- PM Modi prays at Kanpur gurdwara along with CM Yogi
10% growth in pharma exports in FY24
India’s drugs and pharmaceuticals exports increased 9.67 per cent year-on-year to $27.9 billion in 2023-24, even as the total exports dipped by three...
India’s drugs and pharmaceuticals exports increased 9.67 per cent year-on-year to $27.9 billion in 2023-24, even as the total exports dipped by three per cent in the last fiscal.
According to the Commerce Ministry data, pharma exports in March grew by 12.73 per cent to $2.8 billion. In 2022-23, the exports stood at $25.4 billion. The top five export markets, for the sector during the last fiscal, are the US, the UK, the Netherlands, the United Kingdom, South Africa and Brazil.
The US accounts for over 31 per cent of India’s total pharma exports, followed by the UK and Netherlands (about 3% each). In 2023-24, the outbound shipments also entered new geographies like Montenegro, South Sudan, Chad, Comoros, Brunei, Latvia, Ireland, Chad, Sweden, Haiti and Ethiopia.
An industry expert said that increasing market opportunities and healthy demand in countries like the US are helping exports to record healthy growth rates month after month.
